Oncozac® - Serious Illness Patients Caring Program

When patients undergo serious illness treatments, they will commonly encounter side effects (such as loss of appetite, vomiting, etc.)

Through administration of Oncozac®, its active ingredient is proven to be effective in relieving side effects from serious illness treatment, therefore facilitate recovery of the body.

 

In order to introduce more serious illness patients to be benefit from Oncozac®, you are kindly invited to participate in this program. Successful participants will be arranged a FREE consultation hosted by the Chinese-Western medicine combination clinic, as well as a FREE Oncozac® 100 capsules.Please refer to the application details below:

  1. Serious illness patients who are diagnosed, being treated by public or private hospitals in Hong Kong
  2. Hong Kong resident

  1. Filled application form
  2. Proof of the serious illness, such as related medical appointment notes, or invoices issued by Hong Kong public or private hospitals, or specialist clinics
 

Please click “Start Application” below, and complete the required application documents and contents. After application submission, Oncozac specialists will verify your information.

Successful applicants will be informed follow-up details of the plan. If you have any questions, please contact the Oncozac specialists at 2110 0880

Please complete all fields and click "NEXT" to continue with your application. (All fields are mandatory)


Applicant's Information

Full Name:

Contact Number:

Mailing Address:

Gender:

Relationship with patients:

E-Mail:

Source of knowing this Caring Program:

District:


Patient's Information

Full Name:

ID Card initial and first 4 digits:

Serious Illness Category:

Gender:

Age:

Please provide supporting

(You can submit maximum 1 documents each time with total file size not exceeding 5MB. The supported document types include doc, docx, pdf, png, jpg, gif.)

Please provide relative follow up consultation proof/ record issued from Hong Kong Public/ Private Hospitals.


After participating Oncozac® Sponsorship Program, Oncozac® staff will follow your administration status. Before signature confirmation, please AGREE to receive follow up service and promotional materials from PuraPharm International (H.K.) Ltd, or your application will not be accepted. For more information about PuraPharm Privacy Policy Statement, please browse at http://www.purapharm.com/privacy/

Terms and Condition

  1. Each eligible serious illness patients can only apply once, the patients information must be the same as the serious illness related proofs that you provided.
  2. Serious illness should consult with their principle doctors if they have any quires on product efficacy or side effects. PuraPharm International (H.K.) Ltd. will not be responsible for any liability for the administration of Oncozac.
  3. Due to limited resources of the program, we will proceed verified applications in first-come-first-served basis.
  4. The definition of "serious illness" in this program refers to illnesses that rise from normal cell mutation and progressive development to self-control failure, or even transferring to other body parts.
  5. This program is intended for those who are suffering from serious illness instead not patients with common or other special illnesses. If there is any dispute in this program, including but not limited to the eligibility and application of the required contents, PuraPharm International (H.K.) Ltd. reserves the final decision on the application and may reject any application without any reason.
  6. Participation of the program requires the consent of the follow-up service of PuraPharm International (H.K.) Ltd. and subsequent promotional news, otherwise the application will not be accepted.
  7. PuraPharm International (H.K.) Ltd. will act in strict accordance with the PuraPharm Privacy Policy and Personal Data (Privacy) Ordinance (Cap. 486) to ensure that the applicant's personal data will be absolutely confidential. For more information about PuraPharm Privacy Policy, please browse at http://www.purapharm.com/privacy